NCT03928106

Brief Summary

Several previous studies have investigated the impact of a pharmacists-provided medication reconciliation service on medication discrepancies in the hospital settings Results showed that pharmacists were able to identify a range of 1.5-2.3 unintentional discrepancies per patient, leading to a significant reduction of 40-75% of the total identified medication discrepancies. No previous study has investigated the outcomes of involving the clinical pharmacist in a medication reconciliation service in in Jordan. Acknowledging the importance of evaluating the value of medication reconciliation services in the different healthcare settings, this study is designed with the aim to evaluate the effect of pharmacists directed services (reconciliation plus counseling) on reducing medication discrepancies and improving patient's outcomes at discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 30, 2018

Completed
9 months until next milestone

First Posted

Study publicly available on registry

April 25, 2019

Completed
Last Updated

April 25, 2019

Status Verified

April 1, 2019

Enrollment Period

4 months

First QC Date

July 30, 2018

Last Update Submit

April 24, 2019

Conditions

Safety Issues

Keywords

Medication Reconciliation

Outcome Measures

Primary Outcomes (1)

  • The number of accepted recommendations by the clinicians will be documented and recorded, an accepted recommendation, and implemented recommendation

    The number of accepted recommendations by the clinicians will be documented and recorded, an accepted recommendation, implemented recommendation

    From date of randomization until the date of first documented progression, assessed through study completion an average of 3 months

Study Arms (2)

intervention

OTHER

pharmacist responsible for enrollment will administer the following interventions: identifying the medication discrepancies make the recommendations to correct these discrepancies contact the physician to resolve these discrepancies

Other: pharmacists' recommendation

control

OTHER

pharmacists will identify medication discrepancies no recommendation will be written by pharmacists to solve these discrepancies

Other: pharmacists' recommendation

Interventions

pharmacists' recommendationOTHER

For patients in the intervention group, upon identification of drug discrepancies, pharmacist responsible for enrollment will be intervened by contacting the responsible clinician using a structured written consult form. The number of accepted recommendations by the clinicians will be documented and recorded. When the researcher suggests resolving an identified discrepancy and the responsible clinicians accept the suggestion will be called an accepted recommendation (just an acceptance without any correction), if the accepted suggestion is implemented then this will be called implemented recommendation.

controlintervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years
  • using at least 4 regular pre-admission medications
  • more than 48 hours expected length of stay in the hospital
  • speaks Arabic
  • has no cognitive deficiency
  • not involved in any other clinical trial

You may not qualify if:

  • if they were in isolation
  • discharged within 24 hours of admission
  • discharged against medical advice
  • unable or unwilling to provide written informed consent
  • unable to provide a personal phone number
  • if they were admitted to JUH a second time during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan University Hospital

Amman, 00962, Jordan

Location

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Associate professor (Principal Investigator)

Study Record Dates

First Submitted

July 30, 2018

First Posted

April 25, 2019

Study Start

April 1, 2017

Primary Completion

July 30, 2017

Study Completion

July 30, 2017

Last Updated

April 25, 2019

Record last verified: 2019-04

Locations

JO(1)